Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

Chad A. Hamilton, M. K. Cheung, Kathryn Osann et al. · British Journal of Cancer · 2006 · 660 citations · Full text

Medicine, Oncology, Pathology +17

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Carlos Garcı́a-Echeverrı́a, Mark Pearson, Andreas Marti et al. · Cancer Cell · 2004 · 538 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Uterine Papillary Serous Carcinoma: Patterns of Metastatic Spread

Barbara A. Goff, Daniel T. Kato, Rodney A. Schmidt et al. · Gynecologic Oncology · 1994 · 389 citations

Medicine, Oncology, Pathology +12

A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer

Marc J. Gunter, Donald R. Hoover, Herbert Yu et al. · Cancer Epidemiology Biomarkers & Prevention · 2008 · 268 citations · Full text

Medicine, Endocrinology, Oncology +15